LINFOMA B INSORTO NEL CORSO DI UN TRATTAMENTO CICLOSPORINICO IN UN PAZIENTE AFFETTO DA PSORIASI ERITRODERMICA

Translated title of the contribution: B lymphoma during a cyclosporine treatment in an erythrodermic psoriatic patient

B. Giacalone, A. Mastroianni, C. Ferraro, L. D'Auria, A. Amantea, S. Bucher, A. Pittarello

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The paper describes a case of B-lymphoma in a patient suffering from erythrodermic psoriasis treated for sixteen months with intermittent cycles of 3 mg/Kg/die Cyclosporine A. While statistically the incidence of malignant lymphoproliferative diseases in transplanted patients, who later underwent cyclosporine treatments, ranges between 1.4 and 3.6%, only one case of B lymphoma was reported up to now in a psoriatic patient treated continuously for eight months with cyclosporine. In the case described in this paper, the patient underwent intermittent cycles of cyclosporine. Though in this case it was not possible to identify a clear causal connection between the cyclosporine treatment and the onset of the lymphoma, the need was stressed to particularly carefully use this drug in treating skin disease and the so-called severe psoriasis in particular.

Original languageItalian
Pages (from-to)39-43
Number of pages5
JournalGiornale Italiano di Dermatologia e Venereologia
Volume131
Issue number1
Publication statusPublished - 1996

Fingerprint

Cyclosporine
Lymphoma
Psoriasis
Therapeutics
Skin Diseases
Incidence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Dermatology

Cite this

Giacalone, B., Mastroianni, A., Ferraro, C., D'Auria, L., Amantea, A., Bucher, S., & Pittarello, A. (1996). LINFOMA B INSORTO NEL CORSO DI UN TRATTAMENTO CICLOSPORINICO IN UN PAZIENTE AFFETTO DA PSORIASI ERITRODERMICA. Giornale Italiano di Dermatologia e Venereologia, 131(1), 39-43.

LINFOMA B INSORTO NEL CORSO DI UN TRATTAMENTO CICLOSPORINICO IN UN PAZIENTE AFFETTO DA PSORIASI ERITRODERMICA. / Giacalone, B.; Mastroianni, A.; Ferraro, C.; D'Auria, L.; Amantea, A.; Bucher, S.; Pittarello, A.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 131, No. 1, 1996, p. 39-43.

Research output: Contribution to journalArticle

Giacalone, B, Mastroianni, A, Ferraro, C, D'Auria, L, Amantea, A, Bucher, S & Pittarello, A 1996, 'LINFOMA B INSORTO NEL CORSO DI UN TRATTAMENTO CICLOSPORINICO IN UN PAZIENTE AFFETTO DA PSORIASI ERITRODERMICA', Giornale Italiano di Dermatologia e Venereologia, vol. 131, no. 1, pp. 39-43.
Giacalone, B. ; Mastroianni, A. ; Ferraro, C. ; D'Auria, L. ; Amantea, A. ; Bucher, S. ; Pittarello, A. / LINFOMA B INSORTO NEL CORSO DI UN TRATTAMENTO CICLOSPORINICO IN UN PAZIENTE AFFETTO DA PSORIASI ERITRODERMICA. In: Giornale Italiano di Dermatologia e Venereologia. 1996 ; Vol. 131, No. 1. pp. 39-43.
@article{cbccdabc47604f10a457236a6277a9a4,
title = "LINFOMA B INSORTO NEL CORSO DI UN TRATTAMENTO CICLOSPORINICO IN UN PAZIENTE AFFETTO DA PSORIASI ERITRODERMICA",
abstract = "The paper describes a case of B-lymphoma in a patient suffering from erythrodermic psoriasis treated for sixteen months with intermittent cycles of 3 mg/Kg/die Cyclosporine A. While statistically the incidence of malignant lymphoproliferative diseases in transplanted patients, who later underwent cyclosporine treatments, ranges between 1.4 and 3.6{\%}, only one case of B lymphoma was reported up to now in a psoriatic patient treated continuously for eight months with cyclosporine. In the case described in this paper, the patient underwent intermittent cycles of cyclosporine. Though in this case it was not possible to identify a clear causal connection between the cyclosporine treatment and the onset of the lymphoma, the need was stressed to particularly carefully use this drug in treating skin disease and the so-called severe psoriasis in particular.",
keywords = "cyclosporine A, lymphoma, psoriasis",
author = "B. Giacalone and A. Mastroianni and C. Ferraro and L. D'Auria and A. Amantea and S. Bucher and A. Pittarello",
year = "1996",
language = "Italian",
volume = "131",
pages = "39--43",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - LINFOMA B INSORTO NEL CORSO DI UN TRATTAMENTO CICLOSPORINICO IN UN PAZIENTE AFFETTO DA PSORIASI ERITRODERMICA

AU - Giacalone, B.

AU - Mastroianni, A.

AU - Ferraro, C.

AU - D'Auria, L.

AU - Amantea, A.

AU - Bucher, S.

AU - Pittarello, A.

PY - 1996

Y1 - 1996

N2 - The paper describes a case of B-lymphoma in a patient suffering from erythrodermic psoriasis treated for sixteen months with intermittent cycles of 3 mg/Kg/die Cyclosporine A. While statistically the incidence of malignant lymphoproliferative diseases in transplanted patients, who later underwent cyclosporine treatments, ranges between 1.4 and 3.6%, only one case of B lymphoma was reported up to now in a psoriatic patient treated continuously for eight months with cyclosporine. In the case described in this paper, the patient underwent intermittent cycles of cyclosporine. Though in this case it was not possible to identify a clear causal connection between the cyclosporine treatment and the onset of the lymphoma, the need was stressed to particularly carefully use this drug in treating skin disease and the so-called severe psoriasis in particular.

AB - The paper describes a case of B-lymphoma in a patient suffering from erythrodermic psoriasis treated for sixteen months with intermittent cycles of 3 mg/Kg/die Cyclosporine A. While statistically the incidence of malignant lymphoproliferative diseases in transplanted patients, who later underwent cyclosporine treatments, ranges between 1.4 and 3.6%, only one case of B lymphoma was reported up to now in a psoriatic patient treated continuously for eight months with cyclosporine. In the case described in this paper, the patient underwent intermittent cycles of cyclosporine. Though in this case it was not possible to identify a clear causal connection between the cyclosporine treatment and the onset of the lymphoma, the need was stressed to particularly carefully use this drug in treating skin disease and the so-called severe psoriasis in particular.

KW - cyclosporine A

KW - lymphoma

KW - psoriasis

UR - http://www.scopus.com/inward/record.url?scp=0029932225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029932225&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0029932225

VL - 131

SP - 39

EP - 43

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 1

ER -